Get Updates Now
Definitive Healthcare goes public with Nasdaq IPO

Transforming data into healthcare intelligence.

17 September 2021 - Definitive Healthcare underwent its long anticipated IPO and is now listed on Nasdaq under the symbol “DH”. GP Bullhound, investors through Fund IV, would like to congratulate the team and specifically the founders for their remarkable achievement.

In a world where healthcare is more complex, global and urgent than ever, there is a clear need to improve efficiency throughout the ecosystem. Definitive Healthcare is a crucial part of solving this need with their cloud-based intelligence platform. Whether you want to increase your sales, develop marketing campaigns or find experts for clinical trials, Definitive’s platform will help you.

GP Bullhound Fund IV became a shareholder in Definitive Healthcare when they acquired Monocl, the leading subscription-based provider of medical and scientific expert data and insights. GP Bullhound Fund IV invested in Monocl in 2019 and has been an active shareholder ever since, as a member of the board, supporting the company through its internationalisation and strategic choices.

Joakim Dal, Partner at GP Bullhound, commented: “The whole healthcare industry is working in a more data-driven way. Definitive, and of course Monocl which we invested in originally, are leading this change. I would like to congratulate Jason Krantz, Björn Carlsson, and the rest of the team for this successful milestone. We are proud to be shareholders in this exceptional business.”

For enquiries, please contact Joakim Dal, Partner, at

About GP Bullhound
GP Bullhound is a leading technology advisory and investment firm, providing transaction advice and capital to the world’s best entrepreneurs and founders. Founded in 1999 in London and Menlo Park, the firm today has 10 offices spanning Europe, the US and Asia. For more information, please visit

Related Articles